iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://doi.org/10.1007/s11882-009-0031-4
Chronic rhinosinusitis with and without nasal polyps: What is the difference? | Current Allergy and Asthma Reports Skip to main content

Advertisement

Log in

Chronic rhinosinusitis with and without nasal polyps: What is the difference?

  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Chronic rhinosinusitis is a heterogeneous group of chronic sinus diseases that may consist of clearly different disease entities. Further investigation of the pathomechanisms of chronic rhinosinusitis and the introduction of appropriate disease markers have recently facilitated disease classification. Evaluation of inflammatory cell profiles, the differentiation of T-effector cells, characterization of remodeling processes such as fibrosis or edema formation, and innate or adaptive immunity products such as Toll-like receptors and immunoglobulins all provide tools to identify distinct disease entities within the group of chronic sinus diseases. This disease differentiation will not only increase our knowledge of the pathophysiology of sinusitis but may lead to new diagnostic and therapeutic strategies specifically targeted and adapted to the diagnosed disease entity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S: The health and productivity cost burden of the “top 10” physical and mental health conditions affecting six large U.S. employers in 1999. J Occup Environ Med 2003, 45:5–14.

    Article  PubMed  Google Scholar 

  2. Ray NF, Baraniuk JN, Thamer M, et al.: Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol 1999, 103:408–414.

    Article  PubMed  CAS  Google Scholar 

  3. Durr DG, Desrosiers MY, Dassa C: Impact of rhinosinusitis in health care delivery: the Quebec experience. J Otolaryngol 2001, 30:93–97.

    Article  PubMed  CAS  Google Scholar 

  4. Gwaltney J: Microbiology of sinusitis. In Sinusitis: Pathophysiology and Treatment. Edited by Druce HM. New York: Marcel Dekker; 1994:41–56.

    Google Scholar 

  5. Baraniuk J: Physiology of sinusitis. In Sinusitis: Pathophysiology and Treatment. Edited by Druce HM. New York: Marcel Dekker; 1994:19–40.

    Google Scholar 

  6. Stammberger H: Endoscopic endonasal surgery-concepts in treatment of recurring rhinosinusitis. Part I. Anatomic and pathophysiologic considerations. Otolaryngol Head Neck Surg 1986, 94:143–147.

    PubMed  CAS  Google Scholar 

  7. Collins JG: Prevalence of selected chronic conditions: United States, 1990–1992. Vital Health Stat 10 1997, Jan:1–89.

    Google Scholar 

  8. Benninger MS: Rhinitis, sinusitis, and their relationships to allergies. Am J Rhinol 1992, 6:37–43.

    Article  Google Scholar 

  9. Ratjen F, Doring G: Cystic fibrosis. Lancet 2003, 361:681–689.

    Article  PubMed  CAS  Google Scholar 

  10. Schubert MS: Allergic fungal sinusitis. Otolaryngol Clin North Am 2004, 37:301–326.

    Article  PubMed  Google Scholar 

  11. Bousquet J, Van Cauwenberge P, Khaltaev N: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108:S147–S334.

    Article  PubMed  CAS  Google Scholar 

  12. Hens G, Vanaudenaerde BM, Bullens DM, et al.: Sinonasal pathology in nonallergic asthma and COPD: ‘united airway disease’ beyond the scope of allergy. Allergy 2008, 63:261–267.

    Article  PubMed  CAS  Google Scholar 

  13. Miles-Lawrence R, Kaplan M, Chang K: Methacholine sensitivity in nasal polyposis and the effects of polypectomy [abstract]. J Allergy Clin Immunol 1982, 69:102.

    Article  Google Scholar 

  14. Blackwell DL, Collins JG, Coles R: Summary health statistics for U.S. adults: National Health Interview Survey, 1997. Vital Health Stat 10 2002, May:1–109.

    Google Scholar 

  15. Chen Y, Dales R, Lin M: The epidemiology of chronic rhinosinusitis in Canadians. Laryngoscope 2003, 113:1199–1205.

    Article  PubMed  Google Scholar 

  16. Gordts F, Clement PA, Buisseret T: Prevalence of sinusitis signs in a non-ENT population. ORL J Otorhinolaryngol Relat Spec 1996, 58:315–319.

    PubMed  CAS  Google Scholar 

  17. Hosemann W, Gode U, Wagner W: Epidemiology, pathophysiology of nasal polyposis, and spectrum of endonasal sinus surgery. Am J Otolaryngol 1994, 15:85–98.

    Article  PubMed  CAS  Google Scholar 

  18. Hedman J, Kaprio J, Poussa T, Nieminen MM: Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999, 28:717–722.

    Article  PubMed  CAS  Google Scholar 

  19. Moloney JR: Nasal polyps, nasal polypectomy, asthma, and aspirin sensitivity. Their association in 445 cases of nasal polyps. J Laryngol Otol 1977, 91:837–846.

    Article  PubMed  CAS  Google Scholar 

  20. Meltzer EO, Hamilos DL, Hadley JA, et al.: Rhinosinusitis: establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 2004, 131:S1–S62.

    Article  PubMed  Google Scholar 

  21. Uffredi ML, Mangiapan G, Cadranel J, Kac G: Significance of Aspergillus fumigatus isolation from respiratory specimens of nongranulocytopenic patients. Eur J Clin Microbiol Infect Dis 2003, 22:457–462.

    Article  PubMed  CAS  Google Scholar 

  22. Ebbens FA, Scadding GK, Badia L, et al.: Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 2006, 118:1149–1156.

    Article  PubMed  CAS  Google Scholar 

  23. Gysin C, Alothman GA, Papsin BC: Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management. Pediatr Pulmonol 2000, 30:481–489.

    Article  PubMed  CAS  Google Scholar 

  24. Coste A, Idrissi F, Beautru R, et al.: [Endoscopic endonasal ethmoidectomy in severe sinusitis of cystic fibrosis. Mid-term results in 12 patients]. Ann Otolaryngol Chir Cervicofac 1997, 114:99–104.

    PubMed  CAS  Google Scholar 

  25. Jones JW, Parsons DS, Cuyler JP: The results of functional endoscopic sinus (FES) surgery on the symptoms of patients with cystic fibrosis. Int J Pediatr Otorhinolaryngol 1993, 28:25–32.

    Article  PubMed  CAS  Google Scholar 

  26. Van Zele T, Claeys S, Gevaert P, et al.: Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006, 61:1280–1289.

    Article  PubMed  Google Scholar 

  27. Bachert C, Gevaert P, Holtappels G, et al.: Nasal polyposis: from cytokines to growth. Am J Rhinol 2000, 14:279–290.

    Article  PubMed  CAS  Google Scholar 

  28. Van Zele T, Gevaert P, Watelet JB, et al.: Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 2004, 114:981–983.

    Article  PubMed  Google Scholar 

  29. Bachert C, Gevaert P, Holtappels G, et al.: Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001, 107:607–614.

    Article  PubMed  CAS  Google Scholar 

  30. Claeys S, Van Hoecke H, Holtappels G, et al.: Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators. Clin Exp Allergy 2005, 35:467–472.

    Article  PubMed  CAS  Google Scholar 

  31. Muhlebach MS, Stewart PW, Leigh MW, Noah TL: Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 1999, 160:186–191.

    PubMed  CAS  Google Scholar 

  32. Van Bruaene N, Perez-Novo CA, Basinski TM, et al.: T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol 2008, 121:1435–1441.

    Article  PubMed  Google Scholar 

  33. Zhang N, Van Zele T, Perez-Novo C, et al.: Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 2008, 122:961–968.

    Article  PubMed  CAS  Google Scholar 

  34. Van Bruaene N, Derycke L, Perez-Novo CA, et al.: TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol 2009 (in press).

  35. Watelet JB, Bachert C, Claeys C, Van Cauwenberge P: Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy 2004, 59:54–60.

    Article  PubMed  CAS  Google Scholar 

  36. Kostamo K, Tervahartiala T, Sorsa T, et al.: Metalloproteinase function in chronic rhinosinusitis with nasal polyposis. Laryngoscope 2007, 117:638–643.

    Article  PubMed  CAS  Google Scholar 

  37. Lechapt-Zalcman E, Coste A, d’Ortho MP, et al.: Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 2001, 193:233–241.

    Article  PubMed  CAS  Google Scholar 

  38. Chen YS, Langhammer T, Westhofen M, Lorenzen J: Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps. Allergy 2007, 62:66–72.

    Article  PubMed  CAS  Google Scholar 

  39. Bachert C, Zhang N, Patou J, et al.: Role of staphylococcal superantigens in upper airway disease. Curr Opin Allergy Clin Immunol 2008, 8:34–38.

    Article  PubMed  CAS  Google Scholar 

  40. Tripathi A, Kern R, Conley DB, et al.: Staphylococcal exotoxins and nasal polyposis: analysis of systemic and local responses. Am J Rhinol 2005, 19:327–333.

    PubMed  Google Scholar 

  41. Patou J, Gevaert P, Van Zele T, et al.: Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps. J Allergy Clin Immunol 2008, 121:110–115.

    Article  PubMed  CAS  Google Scholar 

  42. Van Zele T, Gevaert P, Holtappels G, et al.: Local immunoglobulin production in nasal polyposis is modulated by superantigens. Clin Exp Allergy 2007, 37:1840–1847.

    Article  PubMed  Google Scholar 

  43. Keith PK, Conway M, Evans S, et al.: Nasal polyps: effects of seasonal allergen exposure. J Allergy Clin Immunol 1994, 93:567–574.

    Article  PubMed  CAS  Google Scholar 

  44. Leung DY, Harbeck R, Bina P, et al.: Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest 1993, 92:1374–1380.

    Article  PubMed  CAS  Google Scholar 

  45. Fokkens W, Lund V, Mullol J; European Position Paper on Rhinosinusitis and Nasal Polyps Group: EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology 2007, 45:97–101.

    PubMed  Google Scholar 

  46. Corey JJP, Bumsted RRM: Revision endoscopic ethmoidectomy for chronic rhinosinusitis. Otolaryngol Clin North Am 1989, 22:801–808.

    PubMed  CAS  Google Scholar 

  47. Moses RL, Cornetta A, Atkins JP Jr, et al.: Revision endoscopic sinus surgery: the Thomas Jefferson University experience. Ear Nose Throat J 1998, 77:190.

    PubMed  CAS  Google Scholar 

  48. Senior BA, Kennedy DW, Tanabodee J, et al.: Long-term results of functional endoscopic sinus surgery. Laryngoscope 1998, 108:151–157.

    Article  PubMed  CAS  Google Scholar 

  49. Watelet JB, Claeys C, Van Cauwenberge P, Bachert C: Predictive and monitoring value of matrix metalloproteinase-9 for healing quality after sinus surgery. Wound Repair Regen 2004, 12:412–418.

    Article  PubMed  Google Scholar 

  50. Huvenne W, Zhang N, Tijsma E, et al.: Pilot study using doxycycline-releasing stents to ameliorate postoperative healing quality after sinus surgery. Wound Repair Regen 2008, 16:757–767.

    PubMed  Google Scholar 

  51. Gevaert P, Lang-Loidolt D, Lackner A, et al.: Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol 2006, 118:1133–1141.

    Article  PubMed  CAS  Google Scholar 

  52. Gevaert P, Holtappels G, Johansson SG, et al.: Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. Allergy 2005, 60:71–79.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wouter Huvenne.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huvenne, W., van Bruaene, N., Zhang, N. et al. Chronic rhinosinusitis with and without nasal polyps: What is the difference?. Curr Allergy Asthma Rep 9, 213–220 (2009). https://doi.org/10.1007/s11882-009-0031-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-009-0031-4

Keywords

Navigation